1504-49-0 Usage
Uses
Used in Pharmaceutical Industry:
(4-aminocyclohexyl)methanol is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the formation of complex molecular structures that can exhibit therapeutic effects.
Used in Agrochemical Industry:
(4-aminocyclohexyl)methanol is used as a precursor in the production of agrochemicals, leveraging its chemical reactivity to create compounds that can be applied in agricultural settings for pest control or crop enhancement.
Used in Dye Industry:
(4-aminocyclohexyl)methanol is used as a starting material in the synthesis of dyes, where its unique structure can be manipulated to produce a range of colorants for various applications.
Used in Organic Synthesis:
(4-aminocyclohexyl)methanol is used as a versatile precursor for the synthesis of other important organic compounds, highlighting its role in creating new chemical entities with potential applications across different industries.
Used in Corrosion Inhibition:
(4-aminocyclohexyl)methanol is studied for its potential as a corrosion inhibitor in various industrial applications, where its chemical properties can be utilized to protect materials from degradation and extend their service life.
Check Digit Verification of cas no
The CAS Registry Mumber 1504-49-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,0 and 4 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1504-49:
(6*1)+(5*5)+(4*0)+(3*4)+(2*4)+(1*9)=60
60 % 10 = 0
So 1504-49-0 is a valid CAS Registry Number.
1504-49-0Relevant articles and documents
TRI-SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AS PDE10 INHIBITORS
-
Page/Page column 28; 49, (2011/07/08)
The present invention provides a tri-substituted pyrimidine compound having an excellent PDE10 inhibitory activity. The present invention relates to a tri-substituted pyrimidine compound represented by the following formula [I0] or a pharmaceutically acceptable salt thereof, a method for preparing the same, and use of said compound for PDE10 inhibitor, and a pharmaceutical composition comprising said compounds as an active ingredient: wherein: either one of X1 and X2 is N, and the other of X1 and X2 is CH; A is *-CH═CH—, *-C(Alk)=CH—, *-CH2—CH2— or *-O—CH2— (* is a bond with R1); Alk is a lower alkyl group; Ring B is an optionally substituted nitrogen-containing aliphatic heterocyclic group; R1 is an optionally substituted quinoxalinyl or an optionally substituted quinolyl; Y0 is mono- or di-substituted amino group, or a pharmaceutically acceptable salt thereof.
N-substituted piperidines and their use as pharrmaceuticals
-
Page/Page column 44, (2010/02/15)
The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.